Ucb SA
XBRU:UCB

Watchlist Manager
Ucb SA Logo
Ucb SA
XBRU:UCB
Watchlist
Price: 169.7 EUR 0.3% Market Closed
Market Cap: 33B EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+25%
Revenue
Forecast
+12%
Operating Income
Forecast
+44%
Net Income
Forecast
+30%

Wall Street
Price Targets

UCB Price Targets Summary
Ucb SA

Wall Street analysts forecast UCB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UCB is 211.54 EUR with a low forecast of 148.47 EUR and a high forecast of 262.5 EUR.

UCB Lowest Forecast
Wall Street Target
148.47 EUR
13% Downside
UCB Average Forecast
Wall Street Target
211.54 EUR
25% Upside
UCB Highest Forecast
Wall Street Target
262.5 EUR
55% Upside
Lowest
Price Target
148.47 EUR
13% Downside
Average
Price Target
211.54 EUR
25% Upside
Highest
Price Target
262.5 EUR
55% Upside
Ucb SA Competitors:
Price Targets
MARKSANS
Marksans Pharma Ltd
37% Upside
E
EMCURE
Emcure Pharmaceuticals Ltd
54% Upside
4547
Kissei Pharmaceutical Co Ltd
8% Upside
MYX
Mayne Pharma Group Ltd
8% Upside
MARKSANS
Marksans Pharma Ltd
37% Upside
E
EMCURE
Emcure Pharmaceuticals Ltd
54% Upside
4547
Kissei Pharmaceutical Co Ltd
8% Upside
MYX
Mayne Pharma Group Ltd
8% Upside
4551
Torii Pharmaceutical Co Ltd
13% Downside
PBH
Prestige Consumer Healthcare Inc
9% Upside
D
086450
Dongkook Pharmaceutical Co Ltd
71% Upside

Revenue
Forecast

Revenue Estimate
Ucb SA

For the last 8 years the compound annual growth rate for Ucb SA's revenue is 5%. The projected CAGR for the next 3 years is 12%.

5%
Past Growth
12%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Ucb SA

For the last 8 years the compound annual growth rate for Ucb SA's operating income is 1%. The projected CAGR for the next 3 years is 44%.

1%
Past Growth
44%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Ucb SA

For the last 8 years the compound annual growth rate for Ucb SA's net income is 9%. The projected CAGR for the next 3 years is 30%.

9%
Past Growth
30%
Estimated Growth
Estimates Accuracy
-12%
Average Miss
What are analyst estimates?

See Also

Summary
UCB intrinsic value, competitors valuation, and company profile.
DCF Valuation
UCB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UCB stock valuation using valuation multiples.
Wall Street Estimates
UCB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UCB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is UCB's stock price target?
Price Target
211.54 EUR

According to Wall Street analysts, the average 1-year price target for UCB is 211.54 EUR with a low forecast of 148.47 EUR and a high forecast of 262.5 EUR.

What is Ucb SA's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Ucb SA's revenue is 5%. The projected CAGR for the next 3 years is 12%.

What is Ucb SA's Operating Income forecast?
Projected CAGR
44%

For the last 8 years the compound annual growth rate for Ucb SA's operating income is 1%. The projected CAGR for the next 3 years is 44%.

What is Ucb SA's Net Income forecast?
Projected CAGR
30%

For the last 8 years the compound annual growth rate for Ucb SA's net income is 9%. The projected CAGR for the next 3 years is 30%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 252,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.